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Edited by Stuart FergusonAbstract Glutamine synthetase (GS) plays a key role in two ma-
jor biochemical pathways: In liver GS catalyzes ammonia detox-
iﬁcation, whereas in neural tissues it also functions in recycling of
the neurotransmitter glutamate. In most species the GS gene gives
rise to a cytoplasmic protein in both liver and neural tissues. How-
ever, in species that utilize the ureosmotic or uricotelic system for
ammonia detoxiﬁcation, the enzyme is cytoplasmic in neural
tissues, but mitochondrial in liver cells. Since most vertebrates
have a single copy of the GS gene, it is not clear how tissue-
speciﬁc subcellular localization is achieved. Here we show that
in the ureosmotic elasmobranch, Squalus acanthias (spiny dog-
ﬁsh), two diﬀerent GS transcripts are generated by tissue-speciﬁc
alternative splicing. The liver transcript contains an alternative
exon that is not present in the neural one. This exon leads to
acquisition of an upstream in-frame start codon and formation
of a mitochondrial targeting signal (MTS). Therefore, the liver
product is targeted to the mitochondria while the neural one is re-
tained in the cytoplasm. These ﬁndings present a mechanism in
which alternative splicing of an MTS-encoding exon is used to
generate tissue-speciﬁc subcellular localization.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Glutamine synthetase (GS; L-glutamate: ammonia ligase;
EC 6.3.1.2) is considered to be one of the oldest existing func-
tioning genes in evolution [1]. The GS enzyme catalyzes the
ATP-dependent formation of glutamine from glutamate and
ammonia and, in all species, plays a key role in a number of
biochemical pathways. In neural tissue GS contributes to
ammonia detoxiﬁcation, but also functions in recycling of
the neurotransmitter glutamate, a task that requires localiza-
tion of the enzyme to the cytoplasm of glial cells [2–5]. In liver,
GS plays a role in ammonia detoxiﬁcation, and its subcellular
localization varies between species in accordance with the dif-
ferent systems of ammonia detoxiﬁcation developed in the
course of evolution.*Corresponding author. Fax: +972 3 640 6834.
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doi:10.1016/j.febslet.2005.08.082While there are many variations on the detoxiﬁcation of
ammonia, especially in ﬁshes [6], three main systems are uti-
lized. (i) The ureotelic system, exists in all mammals and detox-
iﬁes ammonia by converting it to the ﬁnal excreted product,
urea. GS does not participate in the production of urea in
the majority of liver cells (periportal hepatocytes); instead, it
is expressed in a 2- to 3-cell-thick layer of liver cells (pericentral
hepatocytes) surrounding the eﬀerent central veins, and func-
tions in extrahepatic ammonia detoxiﬁcation [7]. The expres-
sion of GS in these hepatocytes is conﬁned to the cytoplasm
[7]. (ii) The uricotelic system, present in birds, squamate
reptiles and crocodilians. In this system intramitochondrially
created ammonia is converted to glutamine by the action of
GS, and this is followed by synthesis of the excreted ﬁnal prod-
uct, uric acid [8–10]. The hepatic GS in these species is conﬁned
to the mitochondria of all liver cells [10,11]. (iii) The ureos-
motic system, has developed in elasmobranchs (sharks, skates
and rays), and – as in the ureotelic system in mammals – its
ﬁnal product is urea [12–15]. In elasmobranchs, as opposed
to mammals, urea is retained as an osmolyte for osmoregula-
tion [14–17]. Moreover, the biochemical mechanism of ammo-
nia detoxiﬁcation in elasmobranchs, unlike that in mammals,
requires GS function in the initial step of urea synthesis, an
activity that takes place in the mitochondria of all liver cells
[13,14]. The GS enzyme in liver cells of elasmobranchs is there-
fore localized to the mitochondrial matrix. Thus, development
of the diﬀerent systems of ammonia detoxiﬁcation, in particu-
lar the uricotelic and ureosmotic systems was ultimately depen-
dent on the development of mechanisms that facilitate the
expression of a cytoplasmic GS in neural tissues and a mito-
chondrial isoform in liver cells. The molecular mechanism that
controls GS expression in liver and neural tissues was exten-
sively studied by us and by others [18–23]. However, the basis
for the tissue-speciﬁc subcellular localization of GS remained
largely unknown.
Proteins targeted to the mitochondrial matrix are often
expressed as a pre-polypeptide with an N 0-terminal extension
that contains a mitochondrial targeting signal (MTS). Sequen-
ces for targeting proteins to the mitochondrial matrix are usu-
ally between 10 and 80 amino acids long and are capable of
forming an amphipathic transmembrane a-helix that is rich
in basic and hydroxyl residues and lacks acidic residues
[24,25]. Once inside the matrix, the MTS sequences are proteo-
lytically cleaved [26]. Mitochondrial import machinery is
highly conserved across distantly related species [27], while
MTS sequences have no consensus sequence and show mar-
ked variation both in and between species [28,29]. The mostblished by Elsevier B.V. All rights reserved.
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to diﬀerent subcellular locations in a tissue-speciﬁc manner is
to maintain two copies of the gene. This is the case, for exam-
ple, in Drosophila melanogaster, which contains two distinct
GS genes [30]: one encodes a GS isoform that contains a
MTS and is targeted to the mitochondria, whereas the other
encodes an isoform that lacks a MTS and is retained in the
cytoplasm [30]. Birds and elasmobranchs, however, contain a
single GS gene [31,32], which apparently arose from a gene
sharing common ancestry with the D. melanogaster cytoplas-
mic GS [32]. Studies by Campbell and co-workers [2] have
clearly demonstrated that the elasmobranch spiny dogﬁsh
(referred to here as dogﬁsh) and the stingray (Dasyatis sabina)
express two isoforms of GS: a large isoform in liver cells and a
smaller isoform in neural tissue. They have also shown that the
liver isoform occurs mainly in the mitochondrial compartment,
whereas that of the brain is localized to the cytoplasm. They
hypothesized that the molecular mechanism that underlies
the tissue-speciﬁc formation of the mitochondrial and cyto-
plasmic isoforms relies on either diﬀerent transcription ini-
tiation sites or diﬀerential translation from the same mRNA
[32].
Here we demonstrate that formation of neural and liver iso-
forms and diﬀerential subcellular localization is controlled by
tissue-speciﬁc alternative splicing. The liver transcript, unlike
the neural one, contains an alternative exon with an in-frame
upstream AUG (uAUG). Fusion of the 5 0 end of liver or
neural GS transcription variants with the EGFP vector re-
vealed that translation from the uAUG led to addition of a
mitochondrial targeting signal that localized the protein to
the mitochondria. We also show that the pattern of splicing
might be inﬂuenced by the cellular amount of the GS tran-
script. Our ﬁndings present a mechanism for tissue-speciﬁc
subcellular localization of a protein product from a single
gene.2. Materials and methods
2.1. Tissue preparations
Dogﬁsh were obtained at the Marine Biological Laboratory,
Woods Hole, MA. Procedures used received prior approval from
the Institutions Animal Welfare Committee. The animals were sacri-
ﬁced by placing them in sea water containing 0.5% MS-222 (Tricaine
Methane sulfonate). Livers and spinal cords were removed and imme-
diately frozen on dry ice.2.2. Plasmid construction
The 5 0 region of dogﬁsh GS was generated by nested PCR of geno-
mic DNA using the following oligonucleotide primers, which are based
on the published dogﬁsh liver GS mRNA (GenBank Accession No.
U04617): 5 0-CATTCAGTAGCCCTTTCCAG-3 0 (primer 1) and 5 0-
TGTGCCGTCTATCCAGATGT-30 (primer 2) for the ﬁrst round,
and 5 0-GCCCCCTATCAAGGAACTT-3 0 (primer 3) and 5 0-CTTG-
CACCTTGCCATCTTG-30 (primer 4) for the second round. The
PCR product was cloned into the pGEM T-easy (Promega, Madison,
WI) vector (p-GS) and sequenced. First-strand cDNA, generated from
RNA samples of dogﬁsh liver and spinal cord tissues (see below), were
ampliﬁed by PCR using primers 2 and 3. The spinal cord and liver
PCR products were cloned into the pGEM T-easy vector (pS-GS
and pL-GS, respectively) and sequenced. Enhanced green ﬂuorescent
protein (EGFP) expression vectors were constructed on the backbone
of pEGFP-N1 (Clontech, Palo Alto, CA), which contains the EGFP
gene under the control of the CMV promoter. The 5 0 region of the dog-
ﬁsh GS gene (pGS-EGFP) was ampliﬁed by PCR from p-GS. The 5 0
regions of the liver (pL-GS-EGFP) and spinal cord GS transcripts(pS-GS-EGFP) were ampliﬁed by PCR from pL-GS and pS-GS,
respectively, and ligated in-frame upstream of EGFP. The oligonu-
cleotide primers 5 0-AAGCTTGCCCCCTATCAAGGAAC-3 0 and
5 0-AGATCTTGCACCTTGCCATCTTG-3 0, which bear synthetic
HindIII and BglII restriction sites, were used in the PCR. The PCR
products were cloned into the pGEM T-easy vector, excised by diges-
tion with HindIII and BglII and ligated into pEGFP-N1, which was
also digested with HindIII and BamHI. The in-frame insertions of
the diﬀerent PCR products were conﬁrmed by sequencing. All primers
were purchased from Sigma. Plasmids were sequenced by the ABI
PRISM 3100 Genetic Analyzer utilizing the BigDye Terminator
Cycle Sequencing Kit (Applied Biosystems, Foster City, CA).2.3. Cell cultures and transfection procedure
HeLa and C6 cells were cultured in Dulbeccos modiﬁed Eagles
medium (DMEM) supplemented with 10% fetal calf serum. HepG2
cells were cultured in a 1:1 mixture of H12 medium and DMEM
supplemented with 10% fetal calf serum, 10% essential amino acids,
and 10% non-essential amino acids (Beit Haemek Biological Indus-
tries, Beit Haemek, Israel). Unless otherwise indicated, cells were
transfected with 1 lg DNA/5 · 105 cells, using jetPEIe (Polyplus
Transfection, Illkirch, France) according to the manufacturers
instructions. Cells were harvested or microscopically inspected 48 h
after transfection.2.4. RT-PCR analysis
Total RNA was extracted from dogﬁsh liver and spinal cord with
TRI reagent (Molecular Research Center, Cincinnati, OH) according
to the manufacturers instructions, or from transfected cells in culture
using Tri-Pure? Isolation Reagent (Roche Molecular Biochemicals,
Mannheim, Germany) according to the manufacturers instructions.
RNA amounts were quantitatively determined using NanoDrop ND-
1000 spectrophotometer (NanoDrop Technologies, Wilmington,
DE). First-strand cDNA synthesis from dogﬁsh liver and spinal cord
was performed with random-hexamers as primers and the Superscripte
First Strand Synthesis System for RT-PCR (Invitrogen Corp.,
Carlsbad, CA). First-strand cDNA synthesis from transfected cells in
culture was performed using the iScript cDNA synthesis kit (Bio-
Rad Laboratories, Hercules, CA) according to the manufacturers
instructions.
First-strand cDNA of dogﬁsh tissues was ampliﬁed by PCR (30 cy-
cles) using GS primers 1–4, as indicated. First-strand cDNA of the
transfected mammalian cells was ampliﬁed by PCR for the indicated
numbers of cycles using GS primers 3 and 4 and the primers 5 0-CCA-
GAACATCATCCCTGC-3 0 and 5 0-GGAAGGCCATGCCAGTGA-
GC-3 0 for the endogenous mammalian GAPDH. PCR products were
analyzed on 1.8% agarose gel and visualized with ethidium bromide.
The bands were scanned and quantitatively determined using Image-
Master 1D (version 3.01) software.2.5. Analysis of subcellular localization
Cells were analyzed for EGFP localization 48 h after transfection.
The cells were washed with buﬀer B (2 mM CaCl2 in Tris-buﬀered
saline), ﬁxed with 4% paraformaldehyde for 30 min at room tempera-
ture, and washed twice with buﬀer B. For immunostaining, cells were
permeabilized with 0.1% Triton X-100 (Sigma) for 10 min at room
temperature and washed twice with buﬀer B. Non-speciﬁc binding
was blocked by incubation of the permeabilized cells for 30 min with
buﬀer A (2 mM CaCl2, 2% bovine serum albumin in Tris-buﬀered
saline) containing 200 lg/ml of normal goat IgG (Jackson ImmunoRe-
search Laboratories, West Grove, PA). The cells were then incubated
with buﬀer A containing 10 lg/ml of mouse anti cytochrome c anti-
body (6H2.B4; Pharmingen, San Diego, CA), washed three time with
buﬀer A, and incubated for an additional 30 min with buﬀer A con-
taining 2 lg/ml of Cy3-labeled goat anti mouse antibodies (Jackson
ImmunoResearch). After three washes with buﬀer A, the cover slips
were air-dried and mounted with Mowiol containing 29 nM n-propyl
gallate (Sigma). Confocal imaging was performed using a Zeiss 510
confocal laser scanning microscope. Green EGFP ﬂuorescence was
collected using 488 nm excitation and a 505–530 nm band-pass ﬁlter.
Red ﬂuorescence (Cy-3) marker for mitochondria was examined using
543 nm excitation and a 560 nm long-pass ﬁlter. The images were
taken in a multitracking mode.
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3.1. Alternative splicing of dogﬁsh GS mRNA in liver and spinal
cord
To investigate the molecular basis for diﬀerential compart-
mentalization of GS in neural and liver tissues, we examined
whether the 5 0 end of the neural GS transcript diﬀers from that
of the previously cloned and sequenced transcript of liver GS
[32]. RNA samples from liver and spinal cord tissue were ana-
lyzed by RT-PCR, using primers ﬂanking a region of about
200-bp containing two in-frame AUG sequences at the 5 0
end of the liver GS mRNA (Fig. 1A). The PCR products gen-
erated by the various primer combinations clearly demon-
strated that the major neural PCR product was shorter by
about 100-bp than that of the liver (Fig. 1B), although a faint
band of the larger product was also occasionally detected.
Sequence analysis of the major PCR product from the liver
and from the spinal cord conﬁrmed that the two were identical
except for a 95-bp fragment present in the transcript from the
liver and absent from that of the spinal cord (Fig. 2A; Gen-
Bank Accession Nos. AY912482 and AY912483). Because
the elasmobranch genome contains a single GS gene [32], the
observed diﬀerence between the liver and spinal cord GS tran-
scripts raised the possibility that the transcripts had been gen-
erated by tissue-speciﬁc alternative splicing. To examine this
possibility, we cloned the 5 0 region of the dogﬁsh GS gene
(GenBank Accession No. AY787786) and compared its
sequence to those of the liver and spinal cord transcripts.
The result, shown in Fig. 2B, disclosed that the 5 0 end of the
neural transcript is composed of two exons with a translation
initiation codon in exon 2. The 95-bp fragment insertion found
in the liver transcript originated from the ﬁrst intron and
contained the splicing consensus of AG and GT at its 3 0 and
5 0 ends, respectively. It represents an additional exon, which
we termed exon 1 0, and which was evidently generated in dog-
ﬁsh liver cells by alternative splicing. Most importantly, exonFig. 1. RT-PCR analysis of liver and spinal cord GS transcripts. (A)
Schematic representation of liver GS mRNA. The primers used for
RT-PCR are shown as numbered arrows with arrowheads indicating
the 3 0 end. The position of the ﬁrst nucleotide at the 5 0 end of each
primer relative to the transcriptional start site is indicated by the
numbers below. (B) Results of RT-PCR analyses of liver (lanes 1–3)
and spinal cord (lanes 4–6) RNA samples using the indicated primers.1 0 contained an upstream initiation codon (uAUG), which
was located in frame with the initiation codon in exon 2.
The selective presence of exon 1 0 in the liver transcript implies
that GS translation in neural and liver tissues is initiated at
diﬀerent AUGs, yielding protein products that diﬀer in size
and vary in residues at their N 0-terminal ends. This ﬁnding
agrees well with studies demonstrating that the in vivo and
in vitro translation products of mRNA from liver have a higher
molecular weight than those of the brain [2].
3.2. Splice variants can direct subcellular localization of EGFP
Diﬀerences in the proteins N 0-terminal residues as a result of
tissue-speciﬁc alternative splicing might account for the diﬀer-
ential compartmentalization of the GS protein. Inspection of
the N 0 terminal residues by several mitochondrial presequence
prediction programs (Mitoprot, TargetP, and Predotar) indeed
revealed a high (68–96%) probability of mitochondrial target-
ing for the liver isoform and a low (11–40%) probability for the
neural one. The eﬀect of the alternative splicing on protein sub-
cellular localization was directly assessed by fusing the RT-
PCR products generated from liver and spinal cord RNA to
the reading frame of the reporter gene, EGFP (Fig. 3A). These
liver (pL-GS-EGFP) and spinal cord (pS-GS-EGFP) splice
constructs encoded similar chimeric proteins except for an
extension of 29 amino acids at the N-terminus of the liver
chimeric product (depicted in bold in Fig. 3A).
The splice constructs were transfected into HeLa cells and
the subcellular localization of their protein products was
assayed. To identify mitochondrial localization, the cells were
stained with anti cytochrome c antibodies. It should be noted
that not all cells were transfected, and consequently more cells
were seen to be immunostained than expressing EGFP. In cells
transfected with the control pEGFP-N1 reporter construct,
EGFP was homogenously distributed in the cytoplasm and
nucleus (Fig. 3B, upper panels). A similar pattern was obser-
ved in cells transfected with the spinal cord splice construct
pS-GS-EGFP (Fig. 3B, middle panels); the chimeric EGFP
was homogenously distributed, indicating that the attached
GS residues did not contain any unique localization signal.
However, in cells transfected with the liver splice construct
pL-GS-EGFP, the pattern diﬀered markedly, and the chimeric
EGFP was retained almost exclusively in the mitochondria
(Fig. 3B, lower panels). This ﬁnding demonstrates that the
29 N 0-terminal GS residues expressed uniquely by the liver
splice variant were suﬃcient to preclude nuclear import and
promote mitochondrial localization. Our ﬁndings thus indicate
that the presence of exon 1 0 in the liver GS transcript leads to
acquisition of an upstream in-frame start codon and the trans-
lation of a product with the necessary information for an
N 0-terminal MTS. The inclusion of exon 1 0 in the liver GS
transcript by means of alternative splicing, but not in the
neural transcript, appears to constitute the molecular basis
for tissue-speciﬁc subcellular localization of the GS enzyme
in the dogﬁsh.
3.3. Alternative splicing of dogﬁsh GS in mammalian cells
Recent studies have demonstrated that humans, mice, and
dogs express a second GS transcript as a result of alternative
splicing [33]. In all of these species GS is spliced by inclusion
or exclusion of an alternative exon that is located, as in the
dogﬁsh, inside intron 1. Unlike in elasmobranchs, however,
mammalian GS is a cytoplasmic enzyme and exon 1 0 does
Fig. 3. Subcellular localization of chimeric EGFP fused to the N 0-terminal residues of liver or spinal cord GS splice products. (A) Expression
constructs that contain the 5 0 region of liver (pL-GS-EGFP) or spinal cord (pS-GS-EGFP) GS splice variants, fused to the reading frame of EGFP.
The chimeric proteins are similar except for an N 0-terminal extension of 29 residues (marked in bold) of the liver splice variant. The initial methionine
of the liver and spinal cord chimeric proteins are underlined. (B) HeLa cells were transfected with pS-GS-EGFP (middle panels) or pL-GS-EGFP
(lower panels), or with pEGFP-N1 (upper panels) as a control. Mitochondria were stained using anti cytochrome c antibodies. Confocal images show
phase contrast, mitochondrial staining, EGFP ﬂuorescence, and overlay of EGFP and mitochondrial staining, as indicated. When EGFP localizes to
mitochondria the green and red colors merge and yellow appears in overlay images.
Fig. 2. Sequence analysis of dogﬁsh GS gene and transcripts. (A) Sequence of RT-PCR products obtained from spinal cord (S-GS) and liver (L-GS),
using primers 2 and 3 (see Fig. 1). Translation initiation sites are marked with asterisks. The 95-bp sequence absent from the spinal cord transcript is
marked as a dashed line. (B) The structure of the 5 0 region of the dogﬁsh GS gene is represented, showing relative locations of exons 1 and 2 and the
alternative exon 1 0 ﬂanked by introns 1a and 1b. Exons and introns were named in accordance with the corresponding elements of mammalian GS
[33]. The position of the two ATG sequences is indicated. The splice patterns of liver (L-GS) and spinal cord (S-GS) GS transcripts are indicated by
dotted lines.
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Table 1
Comparison of sequences and locations of GS exon 1 0 splice sites across species
30 Splice site 50 Splice site Intron 1a Exon 10 Intron 1b
Intron 1a/Exon 10 Exon 10/Intron 1b bp Relative length (%) bp Relative length (%) bp Relative length (%)
Shark TAG/tc AT/GTAGG 260 23 95 8 787 69
Human AAG/cg GG/GTGAG 826 28 358 12 1746 60
Mouse CAG/ca GG/GTGAG 916 32 176 6 1782 62
Dog CAG/aa GG/GTGAG 1021 39 120 5 1476 56
Consensus YAG/gt AG/GTRAG
The 50 and 3 0 splice sites of exon 1 0 from dogﬁsh, human, mouse, and dog are presented relative to the sequence of the human consensus splice sites
[36]. Bold upper-case letters denote nucleotides that are identical to the consensus splice sites. Lower-case letters denote nucleotides that are less well
conserved in the consensus sequence. Y indicates T or C, R indicates A or G. The dinucleotides AG and GT are the best-conserved sequences at the
3 0 and 50 splice sites, respectively. The lengths of exon 1 0 and the two parts of intron 1 (introns 1a and 1b) are recorded in base pairs (bp), and
expressed as percentages of the total length of intron 1.
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its relative location within intron 1 is conserved (Table 1). A
comparison of the boundary sequences showed that the sites
of alternative splicing in dogﬁsh GS are similar to those of
mammals (Table 1).
To determine whether the dogﬁsh GS transcript can be
alternatively spliced in mammalian cells, we constructed a
CMV-controlled dogﬁsh GS mini-gene that contained the
3 0 end of exon 1, the entire intron 1, and the 5 0 end of exon 2
fused in- frame to EGFP (Fig. 4A). The gene construct was
transfected into human hepatoma HepG2 cells (liver cells)
and rat glioma C6 cells (glial cells). Since previous studies have
demonstrated that alternative splicing might be inﬂuenced by
the cellular amount of the transcript [34,35], we transfected
the cells with varying amounts of DNA per cell. The transcrip-
tion products were assayed by semi-quantitative RT-PCR
using primers that recognize exons 1 and 2 of the transfected
dogﬁsh GS gene as well as primers that recognize the endoge-
nous GAPDH.
PCR products corresponding in size to both liver and spinal
cord GS splice variants were detected in the two cell lines
(Fig. 4B). Consistently with that observation, the two cell lines
were also found to express EGFP in both the mitochondrial
and the cytoplasmic compartments (not shown). These ﬁnd-
ings show that the mammalian liver and glial cell lines could
faithfully splice the dogﬁsh transcript. However, these cell lines
failed to exhibit an exclusive liver-type or neural-type splicing
pattern of the kind observed in dogﬁsh liver or spinal cord tis-
sues, respectively. The amount of GS products was densito-
metrically determined and normalized relative to that of
GAPDH. As expected, an increase in the amount of the trans-
fected GS gene resulted in an increase in GS transcript accu-
mulation (Fig. 4C). Most interestingly, this increase also
inﬂuenced the pattern of splicing: At low amounts the liver-
type splice variant was dominant, whereas at high amounts
the neural-type splice variant prevailed (Fig. 4D). These ﬁnd-
ings agree well with previous results which suggest that the pat-
tern of splicing is inﬂuenced by the cellular amounts of the
transcript.4. Discussion
In this study we established the mechanism by which the
dogﬁsh generates tissue-speciﬁc, diﬀerentially compartmental-
ized isoforms of the GS gene. GS is present in a single copy
in the elasmobranch genome [32] and is transcribed into aspecies of pre-mRNA under the stringent regulation of tissue-
speciﬁc alternative splicing. The GS pre-mRNA is spliced in
the liver, generating a transcript that includes the expression
of an alternative exon (exon 1 0) between the non-coding exon
1 and the AUG-containing exon 2. Addition of the 95-bp exon
1 0 to the transcript contributes a new in-frame uAUG to the
main GS open reading frame (ORF). By fusing the 5 0 end of
the liver GS transcription variant to EGFP we were able to
demonstrate that translation from the uAUG codon results
in the addition of a MTS that localizes the protein to the mito-
chondria. In contrast, the spinal cord GS transcription variant
does not express exon 1 0 in the ﬁnal processed mRNA and
therefore does not contain the uAUG codon. The spinal cord
variant fused to EGFP displays a subcellular localization pat-
tern similar to that of the control EGFP, indicating that the
attached GS residues do not contain any unique localization
signal. It can, therefore, be concluded that inclusion or exclu-
sion of exon 1 0, by means of alternative splicing, is the funda-
mental mechanism underlying the tissue-speciﬁc diﬀerential
compartmentalization of GS isoforms in the dogﬁsh.
Previous analysis of dogﬁsh GS transcripts by Northern
blotting revealed a single GS transcript of about 4.3 kb in both
liver and brain [7]. This is in apparent contrast to the two types
of transcripts, hepatic and neural, detected in this study by
RT-PCR. It is conceivable that the small size diﬀerence (95
bases) between transcripts of 4.3 kb is below the resolution
limits of Northern blot analysis.
The 29-amino-acid N 0-terminus of liver GS has the general
properties of a typical MTS [32] and scored highly by several
mitochondrial presequence prediction programs. The sequence
also includes a typical cleavage site at between residues +14/
+15 (relative to the uAUG) [32]. Its ability to direct mitochon-
drial localization in mammalian cells supports the contention
that the mitochondrial import machinery is highly conserved
between distantly related species and is capable of recognizing
a wide variety of MTS sequences [27–29]. Using a dogﬁsh GS
mini-gene, we showed that the mammalian cell lines HepG2
and C6 could process the dogﬁsh GS pre-mRNA into the liver
and spinal cord splice variants. This ﬁnding is consistent with
our present observation that the 5 0 and 3 0 splice sites of exon 1 0
in dogﬁsh GS are similar to the consensus sequences in humans
[36]. The mammalian liver and glial cell lines failed, however,
to exhibit an exclusive liver- or neural-type splicing pattern
of the kind observed in corresponding tissues of the dogﬁsh.
This ﬁnding might suggest that: (i) the mammalian cell lines
used in this study lost critical aspects of tissue-speciﬁc alterna-
tive splicing, (ii) the potent CMV promoter, which replaced the
Fig. 4. Semi-quantitative RT-PCR analysis of HepG2 and C6 cells transfected with pGS-EGFP. (A) Schematic representation of the dogﬁsh GS
mini-gene (pGS-EGFP) with the liver-type (L-GS) and the neural-type (S-GS) splice products. Arrows indicate the position of the primers (3 and 4)
used for RT-PCR analysis. (B) HepG2 and C6 cells were transfected with the indicated amounts of pGS-EGFP DNA per 5 · 105 cells. RNA samples
were analyzed by RT-PCR using primers to the transfected dogﬁsh GS and to the endogenous GAPDH. RT-PCR products, obtained after the
indicated number of PCR cycles, were separated by gel electrophoresis and visualized by ethidium bromide. The relative amounts of the two GS
products (L-GS and S-GS) and of GAPDH were quantitatively determined from the band density. The ratio of L-GS to S-GS in each reaction was
calculated and is represented by numbers in italics below (an asterisk indicates that the ratio could not be calculated). (C) Graphic representation of
the cellular amount of the GS transcripts per amount of transfected GS mini-gene, in HepG2 (white triangles) and C6 cells (black squares), at 25 PCR
cycles. The y-axis represents the sum of the two GS transcripts, L-GS and S-GS, in each transfected culture calculated relative to that of the
endogenous GAPDH (arbitrary units) and the x-axis represents the amount of the transfected GS mini-gene (lg DNA per 5 · 105 cells). (D) Graphic
representation of the ratio of liver to spinal cord splice variants per sum of their relative cellular amounts, in HepG2 (white triangles) and C6 cells
(black squares), at 25 PCR cycles. The y-axis represents the ratio of liver (L-GS) to spinal cord (S-GS) splice transcripts in each transfected culture
and the x-axis represents the sum of the GS transcripts per that of GAPDH (arbitrary units). The area above the gridline crossing the 1.0 co-ordinate
on the y-axis indicates ratios favoring the liver splice variant, and the area below that gridline indicates ratios favoring the spinal cord splice variant.
Similar results were obtained in two independent experiments.
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as previously suggested [37], the pattern of splicing and thus
abolished tissue-speciﬁcity, and (iii) the ability to splice GS
in a tissue-speciﬁc manner was not conserved throughout
evolution. Splicing of dogﬁsh GS in mammalian cells was,
however, inﬂuenced by the cellular amounts of its transcript:
when the amount was low the splicing reaction favored the
liver splice variant, whereas an increase in the amount resulted
in a shift towards the spinal cord splice variant. Changes in the
cellular amounts of pre-mRNA also aﬀect selective expressionof the E1A splice variants in adenovirus-infected cells and of
the P-element in Drosophila [34,35]. It was suggested that the
relative strengths of the various splice sites, the limiting
amounts of speciﬁc splicing factors, and the cellular amounts
of pre-mRNA might all determine the pattern of splicing
[34,35]. The signiﬁcance of these ﬁnding to the in vivo tissue-
speciﬁc alternative splicing event in dogﬁsh is not fully under-
stood, however from these results it is plausible that in this and
other alternative splicing events the levels of transcription
inﬂuence the splicing pattern.
G.D. Matthews et al. / FEBS Letters 579 (2005) 5527–5534 5533Our study delineated the mechanism for tissue-speciﬁc alter-
native splicing of dogﬁsh GS by examining liver and spinal
cord tissues as a model. It would be of interest to examine
whether other dogﬁsh tissues, in particular spleen and kidney,
where GS predominantly occurs in the cytoplasm [38] and
mitochondria [39], respectively, also utilize alternative splicing
as a mechanism for subcellular localization.
Alternative splicing of the GS transcript is not unique to
the dogﬁsh; humans, mice, and dogs also express a second
GS transcript that contains an alternative exon [33]. In these
species, the alternative exon (exon 1 0) is also located between
the non-coding exon 1 and the AUG-containing exon 2, but
its inclusion does not contribute a MTS. Exon 1 0 of canine
GS introduces an in-frame uAUG codon that extends the
N 0-terminus of the GS protein and alters its enzymatic prop-
erties [40]. In humans and mice, inclusion of exon 1 0 intro-
duces a small uORF in the 5 0-UTR and downregulates
translation of the GS transcript [33]. Alternative splicing of
the GS transcript in mammals does not display tissue-speciﬁc-
ity of the type seen in the dogﬁsh, and its physiological rele-
vance is unknown. Based on the results presented in this
study, we suggest that alternative splicing of exon 1 0 was orig-
inally developed for plasticity, and allowed the hepatic
ammonia detoxiﬁcation mechanism to evolve without impair-
ing normal brain activity. In elasmobranchs, and possibly
also other marine species that utilize the ureosmotic system,
or that synthesize and excrete urea for other purposes, exon
1 0-encoded MTS allows targeting of GS to the mitochondria,
thereby facilitating operation of the glutamine-utilizing en-
zyme, carbamoyl-phosphate synthetase (CPS)-III. In the
course of tetrapod vertebrate evolution CPS-III was replaced
by the ammonia-utilizing enzyme CPS-I [41,42], thus obviat-
ing the need for mitochondrial GS. The MTS was lost during
the early stages of terrestrial adaptation, but alternative splic-
ing of exon 1 0 was apparently retained. The evolutionary
development of the uricotelic system, found in birds, squa-
mate reptiles and crocodilians, was evidently accompanied
by retargeting of liver GS to the mitochondria. Since birds
were shown to contain a single copy of the GS gene [31], it
is not clear whether mitochondrial retargeting of GS occurred
by reinventing a MTS in exon 1 0 or by an alternative mech-
anism [43]. In any event, the existence of alternative splicing
of exon 1 0 in both elasmobranchs and mammals suggests that
alternative splicing represents an ancient trait of the GS gene
that has been conserved through evolution while assuming
diﬀerent regulatory functions.
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